Evidence map›Paper›PMID 36253030›Full record

ReviewAdvances in chronic kidney disease2022

Natural Language Processing in Nephrology.

Tielman T Van Vleck, Douglas Farrell, Lili Chan

Abstract readReview
In one paragraph

Review in Advances in chronic kidney disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tielman T Van VleckCharles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Douglas FarrellDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Lili ChanCharles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: Lili.Chan@MountSinai.org.

Funding

Improving risk prediction of adverse outcomes in hemodialysis patients by incorporating non-traditional risk factorsK23DK124645 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHAN, LILI · 2021 to 2025
$952k
NIDDK NIH HHS K23 DK124645
6 · The paper itself

Abstract

Unstructured data in the electronic health records contain essential patient information. Natural language processing (NLP), teaching a computer to read, allows us to tap into these data without needing the time and effort of manual chart abstraction. The core first step for all NLP algorithms is preprocessing the text to identify the core words that differentiate the text while filtering out the noise. Traditional NLP uses a rule-based approach, applying grammatical rules to infer meaning from the text. Newer NLP approaches use machine learning/deep learning which can infer meaning without explicitly being programmed. NLP use in nephrology research has focused on identifying distinct disease processes, such as CKD, and extraction of patient-oriented outcomes such as symptoms with high sensitivity. NLP can identify patient features from clinical text associated with acute kidney injury and progression of CKD. Lastly, inclusion of features extracted using NLP improved the performance of risk-prediction models compared to models that only use structured data. Implementation of NLP algorithms has been slow, partially hindered by the lack of external validation of NLP algorithms. However, NLP allows for extraction of key patient characteristics from free text, an infrequently used resource in nephrology.

Indexed as

NephrologyRenal Insufficiency, ChronicAlgorithmsElectronic Health RecordsHumansNatural Language ProcessingMachine learningNephrologyNLP

Identifiers

PMID36253030
PMCPMC9586467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.